Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease

NCT01739517 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

INDIV

Sponsor class

Conditions

Short Bowel Syndrome
Cholestasis

Interventions

DRUG: Omegaven Therapy

Sponsor

Amarnath, Rathna, M.D.